Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines-Reference-Cited by-同舟云学术

Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines

Published:2021-08-01 Issue:4 Volume:4 Page:477-490
ISSN:2573-1599
Container-title:The CRISPR Journal
language:en
Short-container-title:The CRISPR Journal

Author:

Tang Na¹,Zhang Yaoyao²,Shen Zhiqiang¹,Yao Yongxiu²,Nair Venugopal²³⁴

Affiliation:

1. Shandong Binzhou Animal Science and Veterinary Medicine Academy and UK-China Centre of Excellence for Research on Avian Diseases, Binzhou, P.R. China; University of Oxford, Oxford, United Kingdom.

2. The Pirbright Institute and UK-China Centre of Excellence for Research on Avian Diseases, Pirbright, Ash road, Guildford, Surrey, United Kingdom; University of Oxford, Oxford, United Kingdom.

3. The Jenner Institute Laboratories, University of Oxford, Oxford, United Kingdom; and University of Oxford, Oxford, United Kingdom.

4. Department of Zoology, University of Oxford, Oxford, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Biotechnology

Link

https://www.liebertpub.com/doi/pdf/10.1089/crispr.2021.0017

Reference193 articles.

1. Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines

2. Recombinant protein vaccines, a proven approach against coronavirus pandemics

3. Transposon Insertional Mutagenesis in Rice,